Virchow 2011 or how to ID(H) human glioblastoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.Scientific reports · 2016
   Trial
2. Harnessing immunotherapy: cancer vaccines as novel therapeutic strategies for brain tumor.Frontiers in immunology · 2025
   Review
3. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma.Acta neuropathologica · 2024
   Review
4. Childhood Obesity: A Potential Key Factor in the Development of Glioblastoma Multiforme.Life (Basel, Switzerland) · 2022
   Review
5. Chromosomal instability in adult-type diffuse gliomas.Acta neuropathologica communications · 2022
   Review
6. Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles.Biomedicines · 2022
   Review
7. Epidemiology of Anthropometric Factors in Glioblastoma Multiforme-Literature Review.Brain sciences · 2021
   Review
8. Hans Joachim Scherer and His Impact on the Diagnostic, Clinical, and Modern Research Aspects of Glial Tumors.Cureus · 2019
   Review
9. Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies.Frontiers in molecular neuroscience · 2019
   Review
10. Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment.Medical oncology (Northwood, London, England) · 2018
    Review
11. On glioblastoma and the search for a cure: where do we stand?Cellular and molecular life sciences : CMLS · 2017
    Review
12. A sub-pathway based method to identify candidate drugs for glioblastomas.Medical oncology (Northwood, London, England) · 2014
    Article
13. AKT pathway genes define 5 prognostic subgroups in glioblastoma.PloS one · 2014
    Article
14. Tumor metabolism of malignant gliomas.Cancers · 2013
    Article
15. Objective assessment of cancer genes for drug discovery.Nature reviews. Drug discovery · 2013
    Review
16. A novel semi-supervised methodology for extracting tumor type-specific MRS sources in human brain data.PloS one · 2013
    Article

Corrections and comments

• Comment on
  Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as